| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunityBio, Inc. | Director | Stock Option (right to buy) | 77.6K | Jun 11, 2024 | Direct | ||
| UNITED THERAPEUTICS Corp | Director | Stock Options | 2.89K | Jul 25, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | Jul 25, 2024 | 1 | $0 | 4 | Jul 26, 2024 | Director |
| IBRX | ImmunityBio, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| UTHR | UNITED THERAPEUTICS Corp | Jul 13, 2023 | 1 | $0 | 4 | Jul 17, 2023 | Director |
| IBRX | ImmunityBio, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| UTHR | UNITED THERAPEUTICS Corp | Jul 7, 2022 | 1 | $0 | 4 | Jul 8, 2022 | Director |
| IBRX | ImmunityBio, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
| UTHR | UNITED THERAPEUTICS Corp | May 27, 2022 | 3 | -$251K | 4 | May 27, 2022 | Director |
| UTHR | UNITED THERAPEUTICS Corp | Jul 8, 2021 | 1 | $1.19M | 4 | Jul 9, 2021 | Director |
| IBRX | ImmunityBio, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |